Patents by Inventor Rom E Eliaz

Rom E Eliaz has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Methods and compositions with immune therapy for treatment of dementia
    Patent number: 9879076
    Abstract: Novel antibodies, methods and compositions for treatment of a disease which is susceptible to amelioration by the blocking of APP cleavage.
    Type: Grant
    Filed: March 13, 2014
    Date of Patent: January 30, 2018
    Assignee: RAMOT AT TEL AVIV UNIVERSITY LTD.
    Inventors: Sarit Samira, Nurit Rachamim, Michael Tal, Ronald Ellis, Idan Rakover, Rom E. Eliaz, Beka Solomon, Timothy David Jones, Francis Joseph Carr, Polina Rabinovich-Toidman, Meital Sooliman
  • Parenteral formulations of rasagiline
    Patent number: 9308182
    Abstract: This application provides a method of preferentially inhibiting monoamine oxidase A (MAOA) in the brain of a subject relative to in the intestine of the subject comprising parenterally administering to the subject a controlled release formulation comprising a therapeutically effective amount of rasagiline or a pharmaceutically acceptable salt thereof.
    Type: Grant
    Filed: August 16, 2013
    Date of Patent: April 12, 2016
    Assignee: TEVA PHARMACEUTICAL INDUSTRIES, LTD.
    Inventors: Cheryl Fitzer-Attas, Rom E Eliaz, Eran Blaugrund, Aviva Gross, Adi Mayk
  • METHODS AND COMPOSITIONS WITH IMMUNE THERAPY FOR TREATMENT OF DEMENTIA
    Publication number: 20160017025
    Abstract: Novel antibodies, methods and compositions for treatment of a disease which is susceptible to amelioration by the blocking of APP cleavage.
    Type: Application
    Filed: March 13, 2014
    Publication date: January 21, 2016
    Inventors: Sarit SAMIRA, Nurit RACHAMIM, Michael TAL, Ronald ELLIS, Idan RAKOVER, Rom E. ELIAZ, Beka SOLOMON, Timothy David JONES, Francis Joseph CARR, Polina RABINOVICH-TOIDMAN, Meital SOOLIMAN
  • PARENTERAL FORMULATIONS OF RASAGILINE
    Publication number: 20140051767
    Abstract: This application provides a method of preferentially inhibiting monoamine oxidase A (MAOA) in the brain of a subject relative to in the intestine of the subject comprising parenterally administering to the subject a controlled release formulation comprising a therapeutically effective amount of rasagiline or a pharmaceutically acceptable salt thereof.
    Type: Application
    Filed: August 16, 2013
    Publication date: February 20, 2014
    Applicant: Teva Pharmaceutical Industries, Ltd.
    Inventors: Cheryl Fitzer-Attas, Rom E. Eliaz, Eran Blaugrund, Aviva Gross, Adi Mayk
  • Pulmonary surfactant formulations
    Patent number: 8337815
    Abstract: Synthetic pulmonary surfactant compositions comprising dipalmitoyl phosphatidylcholine, phosphatidylglycerol, and essentially neutral lipid, and having essentially no 1-palmitoyl 2-oleoyl phosphatidylglycerol and essentially no palmitic acid are provided. Methods for treating respiratory disease are also provided comprising administering a therapeutically effective amount of a synthetic pulmonary surfactant comprising dipalmitoyl phosphatidylcholine, phosphatidylglycerol, and essentially neutral lipid, and having essentially no 1-palmitoyl 2-oleoyl phosphatidylglycerol and essentially no palmitic acid.
    Type: Grant
    Filed: December 21, 2005
    Date of Patent: December 25, 2012
    Assignee: Discovery Laboratories, Inc.
    Inventors: Maithili Rairkar, Rom E Eliaz, Ralph Niven, Mark E. Johnson